RVL Pharmaceuticals plc Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2020 to Q2 2023

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
RVL Pharmaceuticals plc quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2020 to Q2 2023.
  • RVL Pharmaceuticals plc Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2023 was 99.4M shares, a 18.9% increase year-over-year.
  • RVL Pharmaceuticals plc annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 89.8M shares, a 33.3% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 99.4M +15.8M +18.9% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 99.3M +15.8M +19% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q4 2022 89.8M +22.4M +33.3% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-20
Q3 2022 92.8M +29.8M +47.4% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-10
Q2 2022 83.6M +20.8M +33.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 83.5M +20.8M +33.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 67.4M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-20
Q3 2021 62.9M +160K +0.26% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 62.8M +3.9M +6.63% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 62.7M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q3 2020 62.8M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 58.9M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.